Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Cesar, Picado"'
Autor:
Antonio, Castillo Jose, Vicente, Plaza, Gustavo, Rodrigo, Berta, Julia, Cesar, Picado, Cristina, Fernandez, Joaquim, Mullol
Publikováno v:
In Journal of Allergy and Clinical Immunology: Global April 2023
Autor:
Diana Betancor, José María Olaguibel, José Manuel Rodrigo‐Muñoz, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Elena Curto, Victoria DelPozo, Francisco‐Javier González‐Barcala, Carlos Martínez‐Rivera, Joaquim Mullol, Xavier Muñoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto, Antonio Valero, Marcela Valverde‐Monge, Joaquin Sastre
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 8, Pp n/a-n/a (2022)
Abstract Background and Aims Asthma is a heterogeneous respiratory disease that encompasses different inflammatory and functional endophenotypes. Many non‐invasive biomarkers has been investigated to its pathobiology. Heany et al proposed a clinica
Externí odkaz:
https://doaj.org/article/49b9fd54170149758cffdf23b373060c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Irina Bobolea, Cesar Picado
Publikováno v:
Current Treatment Options in Allergy. 9:91-106
Autor:
Monique C. Suarez-Giron, Anabel Castro-Grattoni, Marta Torres, Ramon Farré, Ferran Barbé, Manuel Sánchez-de-la-Torre, David Gozal, Cesar Picado, Josep M. Montserrat, Isaac Almendros
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
Study objectives: Chronic intermittent hypoxia (CIH), a hallmark feature of obstructive sleep apnea (OSA), induces accelerated atherogenesis as well as aorta vascular remodeling. Although the cyclooxygenase (COX) pathway has been proposed to contribu
Externí odkaz:
https://doaj.org/article/697faa529eff4756b5af02e3bde57d4c
Autor:
Rosa Muñoz-Cano, Mariona Pascal, Giovanna Araujo, M. J. Goikoetxea, Antonio L. Valero, Cesar Picado, Joan Bartra
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Anaphylaxis is an acute and life-threatening systemic reaction. Many triggers have been described, including food, drug, and hymenoptera allergens, which are the most frequently involved. The mechanisms described in anaphylactic reactions are complex
Externí odkaz:
https://doaj.org/article/364d02a8764d44dbb97738d190f80d01
Autor:
Marta Gabasa, Dolores Royo, Maria Molina-Molina, Jordi Roca-Ferrer, Laura Pujols, Cesar Picado, Antoni Xaubet, Javier Pereda
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65445 (2013)
BACKGROUND: Prostaglandin E2 (PGE2), the main metabolite of cyclooxygenase (COX), is a well-known anti-fibrotic agent. Moreover, myofibroblasts expressing α-smooth muscle actin (α-SMA), fibroblast expansion and epithelial-mesenchymal transition (EM
Externí odkaz:
https://doaj.org/article/d872f9ec6950430cbe8fb7276b4ad92a
Autor:
Francesc Josep Garcia-Garcia, Joaquim Mullol, Maria Perez-Gonzalez, Laura Pujols, Isam Alobid, Jordi Roca-Ferrer, Cesar Picado
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51281 (2012)
BACKGROUND: Recent studies have revealed that cyclooxygenase-2 (COX-2) expression is down-regulated in aspirin-induced asthma (AIA). Various signal pathways (MAPKs, NF-κB and C/EBP) are involved in COX-2 regulation. OBJECTIVE: To investigate the reg
Externí odkaz:
https://doaj.org/article/efc6c104743a4a6c92b4e82c04b9e217
Publikováno v:
Thorax. 73:782-784
Efficacy of omalizumab in severe asthma is well documented; however, the optimal duration of the treatment remains unclear. In an open prospective study, we sought to assess the persistence of response in subjects withdrawing from omalizumab treatmen